BioSpace News Archive

Chemotherapy-Induced Nausea and Vomiting Treatment Market to Incur US$ 5.7 billion by 2031

Fact.MR – A Market Research and Competitive Intelligence Provider: Chemotherapy-induced nausea and vomiting treatment options are in high demand due to the rising prevalence of cancer and increased adherence to chemotherapy medications.

February 3, 2022

·

7 min read

Business

Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance

Valneva SE a specialty vaccine company, reported its revenue and cash balance for the full year 2021 and provided full year 2022 revenue guidance.

February 3, 2022

·

6 min read

Business

Invitation: Sobi’s Q4 and FY 2021 report

Sobi plans to publish its report for the fourth quarter and full-year 2021 on 10 February 2022 at 08:00 CET.

February 3, 2022

·

1 min read

Tonsillectomy Surgery Devices Market: The Instrument Segment Is Estimated to Account for a Dominant Share of the Market During the Forecast Period

Tonsils are the lymph nodes which are located at each side of the back of the throat. These nodes prevent infections.

February 3, 2022

·

5 min read

Mantle Cell Lymphoma Treatment Market: Rise in the Number of People Suffering from Mantle Cell Lymphoma Is Expected to Drive the Market

Mantle cell lymphoma is a rare form of B-cell non-Hodgkin lymphoma. It is a type of blood cancer that affects white blood cells called lymphocytes.

February 3, 2022

·

5 min read

Endoprosthesis Market: Rise in Prevalence of Peripheral Vascular Diseases to Drive the Market

Endoprosthesis are mechanical devices that can be implanted in human skeleton, cardiovascular system, nervous system, and peripheral vascular system.

February 3, 2022

·

5 min read

Drug Development

Kodiak Sciences Completes Enrollment in GLEAM and GLIMMER Phase 3 Clinical Trials of KSI-301 in Patients with Diabetic Macular Edema

Kodiak Sciences Inc. announced that it has completed enrollment in its GLEAM and GLIMMER Phase 3 clinical trials of KSI-301, Kodiak’s anti-VEGF antibody biopolymer conjugate, in patients with diabetic macular edema.

February 3, 2022

·

11 min read

Business

ITM Announces Key Appointments to its U.S. Leadership Team

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the appointment of three key team members to lead the company’s planned expansion into the U.S. market.

February 3, 2022

·

5 min read

Drug Development

Scientific Reports Publishes INFORAAA Results

Faron Pharmaceuticals Ltd announces that the multidisciplinary journal Scientific Reports from the Nature Publishing Group published research highlighting results from Faron’s Phase II INFORAAA clinical trial.

February 3, 2022

·

8 min read

Pharm Country

Millions of Siemens Healthineers CLINITEST Rapid COVID-19 Antigen Self-Test Now Available in the U.S.

Siemens Healthineers announced the CLINITEST® Rapid COVID-19 Antigen Self-Test1,2 is now available in the U.S. to self-test for the SARS-CoV-2 virus.

February 3, 2022

·

7 min read